- Home
- PRTG vs TXMD Comparison
PRTG vs TXMD Comparison
Compare PRTG & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTG
- TXMD
- Stock Information
- Founded
- PRTG 1973
- TXMD 2008
- Country
- PRTG British Virgin Islands
- TXMD United States
- Employees
- PRTG N/A
- TXMD N/A
- Industry
- PRTG Oil & Gas Production
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- PRTG Energy
- TXMD Health Care
- Exchange
- PRTG Nasdaq
- TXMD Nasdaq
- Market Cap
- PRTG 17.7M
- TXMD 17.1M
- IPO Year
- PRTG N/A
- TXMD N/A
- Fundamental
- Price
- PRTG $5.69
- TXMD $1.18
- Analyst Decision
- PRTG
- TXMD
- Analyst Count
- PRTG 0
- TXMD 0
- Target Price
- PRTG N/A
- TXMD N/A
- AVG Volume (30 Days)
- PRTG 234.2K
- TXMD 69.5K
- Earning Date
- PRTG 08-26-2025
- TXMD 08-11-2025
- Dividend Yield
- PRTG N/A
- TXMD N/A
- EPS Growth
- PRTG N/A
- TXMD N/A
- EPS
- PRTG N/A
- TXMD N/A
- Revenue
- PRTG N/A
- TXMD $1,841,000.00
- Revenue This Year
- PRTG N/A
- TXMD $427.09
- Revenue Next Year
- PRTG N/A
- TXMD N/A
- P/E Ratio
- PRTG N/A
- TXMD N/A
- Revenue Growth
- PRTG N/A
- TXMD 53.55
- 52 Week Low
- PRTG $2.10
- TXMD $0.70
- 52 Week High
- PRTG $23.01
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- PRTG 39.99
- TXMD 47.25
- Support Level
- PRTG $5.24
- TXMD $1.11
- Resistance Level
- PRTG $6.84
- TXMD $1.22
- Average True Range (ATR)
- PRTG 0.76
- TXMD 0.09
- MACD
- PRTG -0.09
- TXMD 0.00
- Stochastic Oscillator
- PRTG 18.10
- TXMD 42.31
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.